Merck KGaA to Add Mobius® Single-Use Bioreactor to Wuxi Plant
Merck KGaA of Germany announced it would make an additional investment to speed up construction of its Wuxi biologic drug manufacturing plant, including a Mobius® single-use bioreactor. The company said the bioreactor would serve biosimilar development in China. It paired the facility in Wuxi with the recently completed Nantong Life Science Center, which makes high-purity inorganic salts, cell culture media products and ready-to-use media for drug discovery and production. More details....
Related Biotechnology, Pharmaceutical and Healthcare News
Stock Symbol: (Xetra: MRK)
Share this with colleagues:
Original Article: Merck KGaA to Add Mobius® Single-Use Bioreactor to Wuxi Plant
NEXT ARTICLE
More From BioPortfolio on "Merck KGaA to Add Mobius® Single-Use Bioreactor to Wuxi Plant"
